White House awards $230M for over-the-counter, rapid COVID-19 tests

The Biden administration is funding the mass production of a rapid, over-the-counter COVID-19 test, White House officials announced Monday.

Andy Slavitt, White House COVID-19 adviser, said the administration will provide more than $230 million to an Australian company called Ellume, which received authorization for the test in December.

The company was part of the National Institutes of Health's RADx initiative to spur test development, and said it received $30 million from the program.